Vascular/Lymphatic Malformation: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(4 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{Stub Notice}} | {{Stub Notice}} | ||
Bleomycin | [https://pubmed.ncbi.nlm.nih.gov/32252098/ High-Flow Vascular Malformations in Children] | ||
[https://pubmed.ncbi.nlm.nih.gov/21668798/ Exsanguination by intent: controlled phlebotomy during resection of a giant vascular malformation in a 22-month-old child] | |||
<b>Bleomycin</b> | |||
[https://pubmed.ncbi.nlm.nih.gov/88070/ The hazards of anesthesia and surgery in bleomycin-treated patients] | [https://pubmed.ncbi.nlm.nih.gov/88070/ The hazards of anesthesia and surgery in bleomycin-treated patients] | ||
[https://www.jvir.org/article/S1051-0443(18)31591-4/fulltext Hyperpigmentation after Foamed Bleomycin Sclerotherapy for Vascular Malformations] |
Latest revision as of 14:47, 26 January 2024
This is a Stub Notice. This page has not been completed. You can work on this page by signing in and going to the Edit tab. Thanks for helping to make PedsAnesthesia.Net Wiki useful.
Go to the Main Page to see the Topic Outline.
Go to the Generalized Suggested Outline for information on case-specific details for each page.
Go to the Test Page for examples on how to use references in the page.
Relevant Article Depot:
High-Flow Vascular Malformations in Children
Bleomycin
The hazards of anesthesia and surgery in bleomycin-treated patients
Hyperpigmentation after Foamed Bleomycin Sclerotherapy for Vascular Malformations